These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 9600123)
1. Up-regulation of CD44 variant exon expression in endometrial carcinomas: analysis of mRNA and protein isoforms, and relation to clinicopathological factors. Saegusa M; Okayasu I Jpn J Cancer Res; 1998 Mar; 89(3):291-8. PubMed ID: 9600123 [TBL] [Abstract][Full Text] [Related]
2. CD44 expression in normal, hyperplastic, and malignant endometrium. Saegusa M; Hashimura M; Okayasu I J Pathol; 1998 Mar; 184(3):297-306. PubMed ID: 9614383 [TBL] [Abstract][Full Text] [Related]
3. CD44 exon v6 is not implicated in the progression and metastasis of endometrial cancer. Tokumo K; Kodama J; Seki N; Miyagi Y; Yoshinouchi M; Kudo T Cancer Lett; 1998 Mar; 125(1-2):221-5. PubMed ID: 9566719 [TBL] [Abstract][Full Text] [Related]
4. The prognostic value of CD44 isoform expression in endometrial cancer. Tempfer C; Haeusler G; Kaider A; Hefler L; Hanzal E; Reinthaller A; Breitenecker G; Kainz C Br J Cancer; 1998 Apr; 77(7):1137-9. PubMed ID: 9569051 [TBL] [Abstract][Full Text] [Related]
5. Frequent expression of the high molecular, 673-bp CD44v3,v8-10 variant in colorectal adenomas and carcinomas. Kopp R; Fichter M; Schalhorn G; Danescu J; Classen S Int J Mol Med; 2009 Nov; 24(5):677-83. PubMed ID: 19787202 [TBL] [Abstract][Full Text] [Related]
6. Expression of CD44 variant exons in acute myeloid leukemia is more common and more complex than that observed in normal blood, bone marrow or CD34+ cells. Bendall LJ; Bradstock KF; Gottlieb DJ Leukemia; 2000 Jul; 14(7):1239-46. PubMed ID: 10914548 [TBL] [Abstract][Full Text] [Related]
7. Down-regulation of CD44 standard and variant isoforms during the development and progression of uterine cervical tumours. Saegusa M; Hashimura M; Machida D; Okayasu I J Pathol; 1999 Jan; 187(2):173-83. PubMed ID: 10365092 [TBL] [Abstract][Full Text] [Related]
8. Glycoprotein CD44 expression in normal, hyperplasic and neoplastic endometrium. An immunohistochemical study including correlations with p53, steroid receptor status and proliferative indices (PCNA, MIB1). Zagorianakou N; Ioachim E; Mitselou A; Kitsou E; Zagorianakou P; Stefanaki S; Makrydimas G; Agnantis NJ Eur J Gynaecol Oncol; 2003; 24(6):500-4. PubMed ID: 14658589 [TBL] [Abstract][Full Text] [Related]
9. Expression of CD44 in normal human versus tumor endometrial tissues: possible implication of reduced expression of CD44 in lymph-vascular space involvement of cancer cells. Fujita N; Yaegashi N; Ide Y; Sato S; Nakamura M; Ishiwata I; Yajima A Cancer Res; 1994 Jul; 54(14):3922-8. PubMed ID: 7518345 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of CD44 variants 6 and 7 in human endometrial cancer. Katsura M; Furumoto H; Nishimura M; Kamada M; Aono T Gynecol Oncol; 1998 Nov; 71(2):185-9. PubMed ID: 9826458 [TBL] [Abstract][Full Text] [Related]
11. Progesterone receptor mRNA variant containing novel exon insertions between exon 4 and exon 5 in human uterine endometrium. Yamanaka T; Hirata S; Shoda T; Hoshi K Endocr J; 2002 Aug; 49(4):473-82. PubMed ID: 12402980 [TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor alpha mRNA variant lacking exon 5 is co-expressed with the wild-type in endometrial adenocarcinoma. Cobellis L; Reis FM; Driul L; Vultaggio G; Ferretti I; Villa E; Petraglia F Eur J Obstet Gynecol Reprod Biol; 2002 Apr; 102(1):92-5. PubMed ID: 12039098 [TBL] [Abstract][Full Text] [Related]
13. Transcription and expression of CD44 variant exons by oro-pharyngeal squamous cell carcinomas. Bloor BK; Rajarajan A; Jaafary-Haghighat K; Odell EW Int J Oncol; 2002 Oct; 21(4):907-13. PubMed ID: 12239634 [TBL] [Abstract][Full Text] [Related]
14. CD44 expression in benign, premalignant, and malignant ovarian neoplasms: relation to tumour development and progression. Saegusa M; Machida D; Hashimura M; Okayasu I J Pathol; 1999 Nov; 189(3):326-37. PubMed ID: 10547593 [TBL] [Abstract][Full Text] [Related]
15. Variant CD44 expression by human fibroblasts. Rajarajan A; Bloor BK; Desai H; Stokes A; Odell EW Biomarkers; 2008 May; 13(3):307-18. PubMed ID: 18415803 [TBL] [Abstract][Full Text] [Related]
16. CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers. Olsson E; Honeth G; Bendahl PO; Saal LH; Gruvberger-Saal S; Ringnér M; Vallon-Christersson J; Jönsson G; Holm K; Lövgren K; Fernö M; Grabau D; Borg A; Hegardt C BMC Cancer; 2011 Sep; 11():418. PubMed ID: 21957977 [TBL] [Abstract][Full Text] [Related]
17. The influence of hormones on CD44 expression in endometrial and breast carcinomas. Durst B; Sorg RV; Röder G; Betz B; Beckmann MW; Niederacher D; Bender HG; Dall P Oncol Rep; 2001; 8(5):987-93. PubMed ID: 11496303 [TBL] [Abstract][Full Text] [Related]
18. Differential expressions of CD44 variants in tumors affecting the central nervous system. Resnick DK; Resnick NM; Welch WC; Cooper DL Mol Diagn; 1999 Sep; 4(3):219-32. PubMed ID: 10553022 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of CD44 variant transcripts in rat transplantable thyroid carcinoma lines demonstrating lung metastasis. Kitahori Y; Cho M; Konishi N; Ohshima M; Matsui E; Ohnishi T; Imai S; Hiasa Y Int J Oncol; 1998 Sep; 13(3):505-11. PubMed ID: 9683785 [TBL] [Abstract][Full Text] [Related]
20. Changes in expression of estrogen receptors alpha and beta in relation to progesterone receptor and pS2 status in normal and malignant endometrium. Saegusa M; Okayasu I Jpn J Cancer Res; 2000 May; 91(5):510-8. PubMed ID: 10835496 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]